News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
News Conference News THT 2025 HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt Todd Neale February 18, 2025
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Conference News ACC 2024 Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF Michael O'Riordan April 06, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
News Conference News THT 2023 More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field Shelley Wood March 24, 2023
News Conference News ESC 2022 New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment Shelley Wood September 01, 2022
News Industry News Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients February 02, 2022
News Daily News Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst L.A. McKeown October 28, 2021
News Conference News TVT 2020 Newer TAVR Devices Reassure in Failed Surgical Valves Shelley Wood June 20, 2020
News Conference News AHA 2019 TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences Yael L. Maxwell November 18, 2019
News Daily News PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’ Shelley Wood October 08, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
News Daily News Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly Michael O'Riordan September 27, 2017
News Conference News ACC 2015 Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension Todd Neale March 17, 2015
News Industry News CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure May 18, 2012